Trial Profile
Impact of early using of DApagliflozin on left ventricular mass and infarct size in patients with STEMI
Status:
Not yet recruiting
Phase of Trial:
Phase 0
Latest Information Update: 03 Dec 2020
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms Dapa-STEMI
- 03 Dec 2020 New trial record